Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens
Abstract Pleural mesothelioma is a rare disease with a dismal prognosis and few therapeutic options. Until recently the median overall survival for a pleural mesothelioma patient was up to 2 years, with few exceptional cases of patients achieving a longer survival. Here, we report the clinical case...
Main Authors: | Luigi Cerbone, Sara Delfanti, Antonina M. De Angelis, Stefania Crivellari, Francesco Boccuzzi, Angela Cimorelli, Marinella Bertolotti, Luisella Righi, Pietro Bertino, Federica Grosso |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14789 |
Similar Items
-
Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report
by: Eleonora Faccioli, et al.
Published: (2024-04-01) -
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score
by: Federica Grosso, et al.
Published: (2021-10-01) -
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01) -
Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01) -
Pleural Mesothelioma: Unexpected Finding in a Young Man
by: Raza Ullah, et al.
Published: (2022-07-01)